C. Topham

发表

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

T. Hickish, C. Boni, J. Tabernero, 2004, The New England journal of medicine.

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

R. Greil, R. Labianca, L. Collette, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.

B. Haylock, C. Topham, L. Samuel, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)

R. Swindell, B. Haylock, C. Topham, 2009, British Journal of Cancer.

Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer.

H. Modjtahedi, C. Topham, H. Thomas, 2005, International journal of oncology.

Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial

D. Kerr, C. McArdle, R. Stephens, 2003, The Lancet.

A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma

C. Topham, M. Seymour, D. Jackson, 2006, British Journal of Cancer.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

T. Hickish, C. Boni, J. Tabernero, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oncosurgery: a new reality in metastatic colorectal carcinoma.

C. Topham, R. Adam, 2002, Seminars in oncology.

Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer: Efficacy results with a median follow-up of 4 years

T. Hickish, C. Boni, J. Tabernero, 2005 .

A 10‐year prospective audit of outcome of surgical treatment for colorectal carcinoma

C. Topham, S. Singh, C. Marks, 1995, The British journal of surgery.

Informal out-patient discussions with patients following surgery for large bowel cancer: are they beneficial?

C. Topham, C. Marks, M. Broughton, 1995, European journal of cancer care.

A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer.

D. Pickering, R. Coleman, C. Topham, 1995, European journal of cancer.

Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years

T. Hickish, C. Boni, J. Tabernero, 2007 .

Continuous vs intermittant chemotherapy for advanced colorectal cancer: preliminary results of the MRC cr06b randomised trial

D. Kerr, C. McArdle, R. Stephens, 2001 .

Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas.

R. Coombes, N. Rawson, C. Topham, 1991, British Journal of Cancer.

FOLFOX4 as adjuvant treatment for stage II colon cancer (CC): Subpopulation data from the MOSAIC trial.

T. Hickish, C. Boni, J. Tabernero, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas.

R. Coombes, C. Topham, J. Glees, 1993, Oncology.

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

Richard J Stephens, Mahesh KB Parmar, M. Parmar, 2007, The Lancet.

Adjuvant Chemotherapy for Testicular Teratoma with Bleomycin and Vinblastine

C. Topham, I. Haywood, F. Madden, 1982, Journal of the Royal Army Medical Corps.

Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.

G. Westbury, E. Newlands, R. Mould, 1976, British Journal of Cancer.

Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients.

H. Modjtahedi, C. Topham, H. Thomas, 2006, International journal of oncology.

The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters.

H. Modjtahedi, C. Topham, H. Thomas, 2004, International journal of oncology.

Once-Weekly Treatment of Anemia in Patients with Cancer: A Comparative Review of Epoetins

E. Pujade-Lauraine, C. Topham, 2005, Oncology.

Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.

E. Van Cutsem, J. Tabernero, D. Haller, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer.

A. Norman, D. Cunningham, P. Ross, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

Christian Jacques, Lucile Awad, David Cunningham, 1998, The Lancet.

Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy

A. Norman, D. Cunningham, P. Ross, 2004, British Journal of Cancer.

Traitement de l’anémie par injection hebdomadaire chez les patients atteints de cancer: analyse comparative des agents stimulants l’érythropoïèse

C. Topham, J. Geay, E. Pujade-lauraine, 2006, Oncologie.

Traitement de l’anémie par injection hebdomadaire chez les patients atteints de cancer: analyse comparative des agents stimulants l’érythropoïèse

C. Topham, J. Geay, E. Pujade-lauraine, 2006, Oncologie.

A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influence of side-effects and administration attributes.

J. Wardle, V. Evans, C. Topham, 1999, European journal of cancer care.

Patient preferences for chemotherapy schedules used in the treatment of advanced colorectal cancer--a pilot study.

C. Topham, J. Moore, 1997, European journal of cancer care.

Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas.

R. Coombes, N. Rawson, C. Topham, 1991, British Journal of Cancer.

Elderly patients with fluoropyrimidine-resistant advanced colorectal cancer (CRC) derive similar benefit without excessive toxicity when treated with irinotecan monotherapy

A. Norman, D. Cunningham, P. Ross, 2004 .